Zobrazeno 1 - 4
of 4
pro vyhledávání: '"William Mezzanotte"'
Autor:
Leonardo M. Fabbri, Claus Vogelmeier, Helen Finnigan, William Mezzanotte, Helgo Magnussen, Guus M. Asijee, Henrik Watz, Kay Tetzlaff, Emiel F.M. Wouters, Bernd Disse, Christoph Hallmann, Peter M.A. Calverley
Publikováno v:
American Journal of Respiratory and Critical Care Medicine, 196(9), 1219-1221. American Thoracic Society
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b5a8fbdc131012479a751722bb1e222
https://cris.maastrichtuniversity.nl/en/publications/fe545864-bb11-428f-9f1a-c7a63c8d136e
https://cris.maastrichtuniversity.nl/en/publications/fe545864-bb11-428f-9f1a-c7a63c8d136e
Autor:
Emmanuelle Clerisme-Beaty, Rozsa Schlenker-Herceg, Simon L.F. Walsh, Hendrik Schmidt, Harold R. Collard, Yoshikazu Inoue, Florence Le Maulf, Athol U. Wells, Luca Richeldi, Kevin R. Flaherty, Vincent Cottin, Kevin K. Brown, Anand Devaraj, William Mezzanotte
Publikováno v:
BMJ Open Respiratory Research
600 patients aged ≥18 years will be randomised in a 1:1 ratio to nintedanib or placebo. Patients with diagnosis of IPF will be excluded. The study population will be enriched with two-thirds having a usual interstitial pneumonia-like pattern on HRC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb7cd035472ca694d42b9169ddc36b81
http://europepmc.org/articles/PMC5604725
http://europepmc.org/articles/PMC5604725
Autor:
Phillip E. Korenblat, Margaret C. Minkwitz, James P. Kemp, William Mezzanotte, Joseph E. Scherger
Publikováno v:
Annals of Allergy, Asthma & Immunology. 84:217-225
Background The Accolate Clinical Experience and Pharmacoepidemiology Trial (ACCEPT), evaluated zafirlukast in a wide spectrum of patients from a variety of clinical practices. Objective To determine the effect of age on the response to zafirlukast 20
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d072405a199c1479856db33f406bc237
https://doi.org/10.1016/s1081-1206(10)62759-7
https://doi.org/10.1016/s1081-1206(10)62759-7
Autor:
William E, Berger, Eugene R, Bleecker, Liza, O'Dowd, Christopher J, Miller, William, Mezzanotte
Publikováno v:
Allergy and asthma proceedings. 31(1)
Asthma guidelines recommend titrating maintenance medications to the lowest effective dose. This study assessed the efficacy and tolerability of reducing the frequency of dosing in patients previously controlled with twice-daily budesonide/formoterol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::030c161f6f356b09af73a2130ff77104
https://pubmed.ncbi.nlm.nih.gov/20167145
https://pubmed.ncbi.nlm.nih.gov/20167145